Back to Market Feed

MYTESI 125 MG DR TABLET

$35.7266per EA

Strength

125 mg/1

Manufacturer

Napo Pharmaceuticals, Inc.

NDC

70564080260

Classification

Brand

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/9/2020

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

8/1/2016

Pharmacological Classes

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+230.0%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LOMOTIL 2.5-0.025 MG TABLET

00025006131•Pfizer Inc.

MOTOFEN 1-0.025 MG TABLET

54766020010•Sebela Pharmaceuticals Inc.